| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |